Visiomed plans €5m IPO to expand international growth
This article was originally published in Clinica
Executive Summary
In another indication that the financial climate for medtech is improving, French home diagnostics specialist Visiomed is planning to raise €5m ($7.2m) in an initial public offering on the NYSE Alternext stock exchange in Paris.